In vitro elution of tobramycin from bioabsorbable polycaprolactone beads

被引:10
作者
Burd, TA
Anglen, JO
Lowry, KJ
Hendricks, KJ
Day, D
机构
[1] Univ Missouri, Dept Orthopaed Surg, Hosp & Clin, Columbia, MO USA
[2] Univ Missouri, Dept Ceram Engn, Rolla, MO 65401 USA
关键词
bioresorbable; infection; polycaprolactone; tobramycin; trauma;
D O I
10.1097/00005131-200108000-00007
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Objectives: To compare the in vitro elution characteristics of tobramycin impregnated beads made of polycaprolactone (PCL) and polymethylmethacrylate (PMMA). Design: Six-millimeter PCL and PMMA beads with 6% tobramycin were formed and placed in phosphate-buffered saline or newborn calf serum and incubated at room temperature or 37 degreesC. Aliquots were taken at intervals for eight weeks. Tobramycin levels were determined by fluorescent assay and antibacterial efficacy was assessed by measuring the zones of inhibition against Staphylococcus aureus and Pseudomonas aeruginosa on agar diffusion plates. Results: Tobramycin elution rates at room temperature were similar up to three weeks. At three weeks, elution rates from PCL beads were twice those from PMMA beads, and at eight weeks, elution from PCL was quadruple that from PMMA. At 37 degreesC, tobramycin elution rates from PCL were eight times greater than those from PMMA by eight weeks. Total tobramycin eluted from PCL beads was 38.9% and 20% in PMMA beads. All samples showed bacteriostatic activity against S. aureus and P. aeruginosa tit eight weeks. Conclusions: These in vitro results show that PCL has superior antibiotic elution characteristics compared with PMMA, and this may translate into a more effective antibiotic delivery vehicle. In addition, PCL is a bioabsorbable polymer, which may decrease the need for a second surgical procedure to remove retained beads.
引用
收藏
页码:424 / 428
页数:5
相关论文
共 39 条
[1]   MECHANISMS OF POLYMER DEGRADATION IN IMPLANTABLE DEVICES .1. POLY(CAPROLACTONE) [J].
ALI, SAM ;
ZHONG, SP ;
DOHERTY, PJ ;
WILLIAMS, DF .
BIOMATERIALS, 1993, 14 (09) :648-656
[2]   DEGRADATION AND TISSUE REPLACEMENT OF AN ABSORBABLE POLYGLYCOLIDE SCREW IN THE FIXATION OF RABBIT FEMORAL OSTEOTOMIES [J].
BOSTMAN, O ;
PAIVARINTA, U ;
PARTIO, E ;
VASENIUS, J ;
MANNINEN, M ;
ROKKANEN, P .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1992, 74A (07) :1021-1031
[3]   FOREIGN-BODY REACTIONS TO FRACTURE FIXATION IMPLANTS OF BIODEGRADABLE SYNTHETIC-POLYMERS [J].
BOSTMAN, O ;
HIRVENSALO, E ;
MAKINEN, J ;
ROKKANEN, P .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1990, 72 (04) :592-596
[4]   BIOCOMPATIBILITY OF A BIODEGRADABLE, CONTROLLED-RELEASE POLYMER IN THE RABBIT BRAIN [J].
BREM, H ;
KADER, A ;
EPSTEIN, JI ;
TAMARGO, RJ ;
DOMB, A ;
LANGER, R ;
LEONG, KW .
SELECTIVE CANCER THERAPEUTICS, 1989, 5 (02) :55-65
[5]  
BROWN R, 1993, 19 ANN M SOC BIOM BI
[6]  
Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
[7]  
CALHOUN JH, 1993, CLIN ORTHOP RELAT R, P23
[8]  
DACQUET V, 1992, CLIN ORTHOP RELAT R, P241
[9]  
DAINERY SL, 1995, CLIN PHARMACOKINET, V29, P36
[10]   AN IMPLANTABLE DOSAGE FORM FOR THE TREATMENT OF BONE-INFECTIONS [J].
DASH, AK ;
SURYANARAYANAN, R .
PHARMACEUTICAL RESEARCH, 1992, 9 (08) :993-1002